MET and cancer: Our hit list contains genes coding kinases with established oncogenic functions such as MET [35], EGFR [36, 37], AKT, mTOR [38–40], RSK2 [41] as well as genes that do not (yet) have an established role in cancer progression (NEK5, SIK2).